Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ·Healthcare·Biotechnology
$31.56
+3.50%
Mkt Cap $2.14B
Analyst Ratings
Buy
13
Hold
3
Sell
0
Price Target (25 analysts)
$41.67
Range $32.00 – $52.00
Implied Upside
+32.1%
Consensus $41.67 vs current $31.56
NASDAQ·Healthcare·Biotechnology
$31.56
+3.50%
Mkt Cap $2.14B
Buy
13
Hold
3
Sell
0
Price Target (25 analysts)
$41.67
Range $32.00 – $52.00
+32.1%
Consensus $41.67 vs current $31.56